Literature DB >> 26568291

microRNA-186 inhibits cell proliferation and induces apoptosis in human esophageal squamous cell carcinoma by targeting SKP2.

Wei He1, Jianfang Feng2, Yan Zhang1, Yuanyuan Wang3, Wenqiao Zang3, Guoqiang Zhao3.   

Abstract

miR-186 has been demonstrated to have a significant role as a tumor suppressor in many types of cancers. Nevertheless, its biological function in esophageal squamous cell carcinoma (ESCC) remains unknown. In the present study, we found that the expression level of miR-186 was downregulated in ESCC in comparison with the adjacent normal tissues and was significantly associated with differentiation level, TNM stage, and lymph node metastasis of ESCC. Functional experiments revealed that enforced overexpression of miR-186 in ESCC cells suppressed the proliferation, invasion, and induced the apoptosis of cells. Luciferase reporter assay and western blotting analysis were performed to verify the target gene regulated by miR-186, SKP2. Our findings established that the miR-186 has a suppressive role in ESCC progression via SKP2-mediated pathway, and this implies that miR-186 could be a potential therapeutic target for ESCC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26568291     DOI: 10.1038/labinvest.2015.134

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  36 in total

1.  Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence.

Authors:  Hui-Kuan Lin; Zhenbang Chen; Guocan Wang; Caterina Nardella; Szu-Wei Lee; Chia-Hsin Chan; Chan-Hsin Chan; Wei-Lei Yang; Jing Wang; Ainara Egia; Keiichi I Nakayama; Carlos Cordon-Cardo; Julie Teruya-Feldstein; Pier Paolo Pandolfi
Journal:  Nature       Date:  2010-03-18       Impact factor: 49.962

2.  miR-186 regulates glycolysis through Glut1 during the formation of cancer-associated fibroblasts.

Authors:  Pan Sun; Jun-Wei Hu; Wu-Jun Xiong; Jun Mi
Journal:  Asian Pac J Cancer Prev       Date:  2014

Review 3.  MicroRNA regulation by RNA-binding proteins and its implications for cancer.

Authors:  Marieke van Kouwenhove; Martijn Kedde; Reuven Agami
Journal:  Nat Rev Cancer       Date:  2011-08-05       Impact factor: 60.716

4.  MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1.

Authors:  Takehiko Yokobori; Shigemasa Suzuki; Naritaka Tanaka; Takanori Inose; Makoto Sohda; Akihiko Sano; Makoto Sakai; Masanobu Nakajima; Tatsuya Miyazaki; Hiroyuki Kato; Hiroyuki Kuwano
Journal:  Cancer Sci       Date:  2012-11-08       Impact factor: 6.716

5.  Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma.

Authors:  Keijiro Sugimura; Hiroshi Miyata; Koji Tanaka; Rie Hamano; Tsuyoshi Takahashi; Yukinori Kurokawa; Makoto Yamasaki; Kiyokazu Nakajima; Shuji Takiguchi; Masaki Mori; Yuichiro Doki
Journal:  Clin Cancer Res       Date:  2012-07-30       Impact factor: 12.531

Review 6.  Engineering RNA for targeted siRNA delivery and medical application.

Authors:  Peixuan Guo; Oana Coban; Nicholas M Snead; Joe Trebley; Steve Hoeprich; Songchuan Guo; Yi Shu
Journal:  Adv Drug Deliv Rev       Date:  2010-03-15       Impact factor: 15.470

7.  Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma.

Authors:  Yong Guo; Zhaoli Chen; Liang Zhang; Fang Zhou; Susheng Shi; Xiaoli Feng; Baozhong Li; Xin Meng; Xi Ma; Mingyong Luo; Kang Shao; Ning Li; Bin Qiu; Keith Mitchelson; Jing Cheng; Jie He
Journal:  Cancer Res       Date:  2008-01-01       Impact factor: 12.701

8.  MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma.

Authors:  Na Wang; Chao-Qi Zhang; Jia-Huan He; Xiao-Fei Duan; Yuan-Yuan Wang; Xiang Ji; Wen-Qiao Zang; Min Li; Yun-Yun Ma; Tao Wang; Guo-Qiang Zhao
Journal:  Dig Dis Sci       Date:  2013-03-17       Impact factor: 3.199

Review 9.  Novel RNA-based strategies for therapeutic gene silencing.

Authors:  Christopher R Sibley; Yiqi Seow; Matthew J A Wood
Journal:  Mol Ther       Date:  2010-01-19       Impact factor: 11.454

10.  MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma.

Authors:  Sheng-Dong Huang; Yang Yuan; Chong-Wen Zhuang; Bai-Ling Li; De-Jun Gong; Shu-Gang Wang; Zhi-Yong Zeng; He-Zhong Cheng
Journal:  Mol Cancer       Date:  2012-08-06       Impact factor: 27.401

View more
  18 in total

1.  Laboratory Investigation web focus on China.

Authors:  Catherine M Ketcham; Akihiro Umezawa; Hejian Zou; Gene P Siegal
Journal:  Lab Invest       Date:  2016-11       Impact factor: 5.662

2.  Dual Functional MicroRNA-186-5p Targets both FGF2 and RelA to Suppress Tumorigenesis of Glioblastoma Multiforme.

Authors:  Fachen Wang; Hui Jiang; Shanjun Wang; Bing Chen
Journal:  Cell Mol Neurobiol       Date:  2017-02-17       Impact factor: 5.046

3.  Natural Killer-Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms.

Authors:  Paolo Neviani; Petra M Wise; Mariam Murtadha; Cathy W Liu; Chun-Hua Wu; Ambrose Y Jong; Robert C Seeger; Muller Fabbri
Journal:  Cancer Res       Date:  2018-12-12       Impact factor: 12.701

4.  Suppression of Disheveled-Axin Domain Containing 1 (DIXDC1) by MicroRNA-186 Inhibits the Proliferation and Invasion of Retinoblastoma Cells.

Authors:  Xuanyi Che; Yuanjie Qian; Di Li
Journal:  J Mol Neurosci       Date:  2017-12-20       Impact factor: 3.444

5.  Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.

Authors:  Dominique Z Jones; M Lee Schmidt; Suman Suman; Katharine R Hobbing; Shirish S Barve; Leila Gobejishvili; Guy Brock; Carolyn M Klinge; Shesh N Rai; Jong Park; Geoffrey J Clark; Rajesh Agarwal; LaCreis R Kidd
Journal:  BMC Cancer       Date:  2018-04-13       Impact factor: 4.430

6.  MiR-506 exerts antineoplastic effects on osteosarcoma cells via inhibition of the Skp2 oncoprotein.

Authors:  Lu Ding; Rongxin Sun; Qi Yan; Chengwei Wang; Xiaoping Han; Yong Cui; Rong Li; Jiwen Liu
Journal:  Aging (Albany NY)       Date:  2021-02-17       Impact factor: 5.682

7.  Inhibition of miR-186-5p contributes to high glucose-induced injury in AC16 cardiomyocytes.

Authors:  Jiamei Jiang; Hailiang Mo; Chang Liu; Bin Wu; Zijun Wu; Xingyue Li; Teng Li; Songjian He; Shanghai Li; Qiong You; Keng Wu; Runmin Guo
Journal:  Exp Ther Med       Date:  2017-11-06       Impact factor: 2.447

8.  Downregulation of miR-186 is associated with metastatic recurrence of gastrointestinal stromal tumors.

Authors:  Takeshi Niinuma; Masahiro Kai; Hiroshi Kitajima; Eiichiro Yamamoto; Taku Harada; Reo Maruyama; Takayuki Nobuoka; Toshirou Nishida; Tatsuo Kanda; Tadashi Hasegawa; Takashi Tokino; Tamotsu Sugai; Yasuhisa Shinomura; Hiroshi Nakase; Hiromu Suzuki
Journal:  Oncol Lett       Date:  2017-09-08       Impact factor: 2.967

9.  Construction of differential mRNA-lncRNA crosstalk networks based on ceRNA hypothesis uncover key roles of lncRNAs implicated in esophageal squamous cell carcinoma.

Authors:  Shuang Yang; Qianqian Ning; Guobin Zhang; Hong Sun; Zhen Wang; Yixue Li
Journal:  Oncotarget       Date:  2016-12-27

10.  Antrodia cinnamomea extract inhibits the proliferation of tamoxifen-resistant breast cancer cells through apoptosis and skp2/microRNAs pathway.

Authors:  Yu-Shih Lin; Yin-Yin Lin; Yao-Hsu Yang; Chun-Liang Lin; Feng-Che Kuan; Cheng-Nan Lu; Geng-He Chang; Ming-Shao Tsai; Cheng-Ming Hsu; Reming-Albert Yeh; Pei-Rung Yang; I-Yun Lee; Li-Hsin Shu; Yu-Ching Cheng; Hung-Te Liu; Kuan-Der Lee; De-Ching Chang; Ching-Yuan Wu
Journal:  BMC Complement Altern Med       Date:  2018-05-09       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.